{"id":"NCT00418457","sponsor":"The Cleveland Clinic","briefTitle":"Regional Anesthesia and Breast Cancer Recurrence","officialTitle":"Regional Anesthesia and Breast Cancer Recurrence","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-01","primaryCompletion":"2018-02","completion":"2019-12","firstPosted":"2007-01-04","resultsPosted":"2020-06-16","lastUpdate":"2020-06-16"},"enrollment":2108,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Breast Neoplasms"],"interventions":[{"type":"DRUG","name":"General anesthesia and opioids","otherNames":["General anesthesia"]},{"type":"DRUG","name":"Regional analgesia and propofol","otherNames":["Regional analgesia"]}],"arms":[{"label":"General anesthesia and opioid","type":"ACTIVE_COMPARATOR"},{"label":"Regional analgesia and propofol","type":"ACTIVE_COMPARATOR"}],"summary":"In this multi-center trial, Stage 1-3 patients having mastectomies or isolated lumpectomy with axillary node dissection will be randomly assigned to thoracic epidural or paravertebral anesthesia/analgesia, or to general anesthesia and morphine analgesia. Participants will be followed for up to 10 years to determine the rate of cancer recurrence or metastasis.","primaryOutcome":{"measure":"Number of Participants Who Had Breast Cancer Recurrence After Breast Cancer Surgery","timeFrame":"up to 10 years","effectByArm":[{"arm":"General Anesthesia and Opioid","deltaMin":111,"sd":null},{"arm":"Regional Analgesia and Propofol","deltaMin":102,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.84"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":6,"countries":["United States","Austria","China","Germany","Ireland","Singapore"]},"refs":{"pmids":["35223519","33187020","31645288","30229370","27866303","26588217","25480319","25009197","25009196"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":1065},"commonTop":[]}}